Quality of Anticoagulation With Phenprocoumon and Warfarin in Left Ventricular Assist Device Patients: A Multicenter Study

Thomas Schlöglhofer; Angelika Marschütz; Pamela Combs; Corinne Stonebraker; Sydney Lupo; Valluvan Jeevanandam; Julia Riebandt; Heinrich Schima; Daniel Zimpfer; Karen Meehan

doi:10.1097/MAT.0000000000001895

Quality of Anticoagulation With Phenprocoumon and Warfarin in Left Ventricular Assist Device Patients: A Multicenter Study

ASAIO J. 2023 Jun 1;69(6):595-601. doi: 10.1097/MAT.0000000000001895. Epub 2023 Feb 23.

Authors

Thomas Schlöglhofer^{1

2

3}, Angelika Marschütz^{1

2}, Pamela Combs⁴, Corinne Stonebraker⁴, Sydney Lupo⁴, Valluvan Jeevanandam⁴, Julia Riebandt¹, Heinrich Schima^{1

2

3}, Daniel Zimpfer^{1

3}, Karen Meehan⁴

Affiliations

¹ From the Department of Cardiac Surgery, Medical University of Vienna, Vienna, Austria.
² Center for Medical Physics and Biomedical Engineering, Medical University of Vienna, Vienna, Austria.
³ Ludwig Boltzmann Institute for Cardiovascular Research, Vienna, Austria.
⁴ Section of Cardiac Surgery, University of Chicago Medical Center, Chicago, Illinois.

PMID: 36821448
DOI: 10.1097/MAT.0000000000001895

Abstract

of key results. INR, international normalized ratio; TTR, time in therapeutic range; PTR, percentage of tests in range; HRAE, hemocompatibility-related adverse event; FFUV, first follow-up visit; GIB, gastrointestinal bleeding; HR, hazard ratio.http://links.lww.com/ASAIO/A961.

Publication types

Multicenter Study
Research Support, Non-U.S. Gov't

MeSH terms

Anticoagulants / adverse effects
Blood Coagulation
Heart-Assist Devices*
Humans
International Normalized Ratio / methods
Phenprocoumon / adverse effects
Warfarin* / adverse effects

Substances

Anticoagulants
Phenprocoumon
Warfarin